As Illumina Cuts Price of Personal Sequencing Service, CEO Says Market Growth Hinges on Analysis

"It's easier and easier to create the datasets — it's increasingly difficult to extract valuable information and figure out how to apply that to an individual," said Illumina CEO Jay Flatley.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.